Low-Profile Visualized Intraluminal Support (LVIS) and LVIS Jr.

Intracranial Coil-assist Stent

FDA Premarket Approval P170013

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the low-profile visualized intraluminal support (lvis) and lvis jr. This device is indicated for use with neurovascular embolization coils in patients >= 18 years of age for the treatment of wide-neck (neck width >= 4 mm or dome to neck ratio < 2) saccular intracranial aneurysms arising from a parent vessel with a diameter >= 2. 0 mm and

DeviceLow-Profile Visualized Intraluminal Support (LVIS) and LVIS Jr.
Classification NameIntracranial Coil-assist Stent
Generic NameIntracranial Coil-assist Stent
ApplicantMicroVention, Inc.
Date Received2017-03-31
Decision Date2018-05-30
Notice Date2018-06-08
PMAP170013
SupplementS
Product CodeQCA
Docket Number18M-2118
Advisory CommitteeNeurology
Expedited ReviewNo
Combination Product No
Applicant Address MicroVention, Inc. 1311 Valencia Avenue tustin, CA 92780
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P170013Original Filing
S010 2022-11-09 Normal 180 Day Track No User Fee
S009 2022-06-10 Normal 180 Day Track No User Fee
S008
S007 2021-09-08 Normal 180 Day Track No User Fee
S006 2021-04-23 Real-time Process
S005
S004
S003 2020-11-24 Normal 180 Day Track No User Fee
S002 2018-09-06 Special (immediate Track)
S001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.